Sari Riihijarvi

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The impact of COVID-19 on healthcare booking and cancellation patterns: time series analysis of private healthcare service utilisation in Finland.

The impact of COVID-19 on healthcare booking and cancellation patterns: time series analysis of private healthcare service utilisation in Finland.

Journal: BMC health services research

Published: October 13, 2023

The impact of COVID-19 on private healthcare service utilisation: time series analysis in the capital region of Finland during 2020-2022.

The impact of COVID-19 on private healthcare service utilisation: time series analysis in the capital region of Finland during 2020-2022.

Journal: BMC public health

Published: September 01, 2023

Time series analysis of the incidence of acute upper respiratory tract infections, COVID-19 and the use of antibiotics in Finland during the COVID-19 epidemic: a cohort study of 833 444 patients.

Time series analysis of the incidence of acute upper respiratory tract infections, COVID-19 and the use of antibiotics in Finland during the COVID-19 epidemic: a cohort study of 833 444 patients.

Journal: BMJ open

Published: February 02, 2022

Cough and cold medicine prescription rates can be significantly reduced by active intervention.

Cough and cold medicine prescription rates can be significantly reduced by active intervention.

Journal: European journal of pediatrics

Published: August 23, 2021

Nationwide infection control strategy lowered seasonal respiratory infection rate: occupational health care perspective during the COVID-19 epidemic in Finland.

Nationwide infection control strategy lowered seasonal respiratory infection rate: occupational health care perspective during the COVID-19 epidemic in Finland.

Journal: Infectious diseases (London, England)

Published: July 01, 2021

Prognostic factors and treatment of diffuse large cell B-cell lymphoma

Prognostic factors and treatment of diffuse large cell B-cell lymphoma

Journal: Duodecim; laaketieteellinen aikakauskirja

Published: January 14, 2015

Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial.

Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial.

Journal: Haematologica

Published: November 09, 2014

High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy.

High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy.

Journal: European journal of haematology

Published: July 26, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026